# ILLUMENATE Pivotal Post-Approval Study (PAS)

> **NCT03421561** · NA · COMPLETED · sponsor: **Spectranetics Corporation** · enrollment: 300 (actual)

## Conditions studied

- Peripheral Artery Disease

## Interventions

- **DEVICE:** Stellarex 0.035" OTW Drug-coated Angioplasty Balloon
- **DEVICE:** EverCross™ 0.035 PTA Balloon Catheter

## Key facts

- **NCT ID:** NCT03421561
- **Lead sponsor:** Spectranetics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-18
- **Primary completion:** 2017-12-08
- **Final completion:** 2020-10-06
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2024-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03421561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03421561, "ILLUMENATE Pivotal Post-Approval Study (PAS)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03421561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*